HIV Market

`

Sort By

1-10 of 16

Page:
  1. 1
  2. 2
  1. Genetic Technology Alert. Novel Genetic Approach to Target Pancreatic Cancer Tumor and Regrowth; Genetic Receptor Changes Related to HIV Treatment Identified
    03
    Jul 2015
    This issue profiles a novel genetic approach to target pancreatic cancer tumor and regrowth, a study to identity genetic receptor changes related to HIV treatment, a study to identity gene types responsible for varying sleep patterns.
    USD 250
    Read More
  2. Genetic Technology Alert. Innovative Cell-Free DNA Blood Test to Detect Down Syndrome; Novel Experimental Vaccine for Ebola; Novel Antibody Therapy to Reduce HIV Loads
    10
    Apr 2015
    This issue profiles an innovative cell-free DNA blood test to detect Down syndrome, a novel experimental vaccine for Ebola, and a novel antibody therapy to reduce HIV loads.
    USD 250
    Read More
  3. A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS
    03
    Jul 2014

    A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

    Antiretroviral Combinations Continue to Transform the Treatment Landscape

    Region : Global

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

    Regular Price: USD 3,950

    Special Price USD 3,555

    Read More
  4. Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS
    26
    Mar 2013

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    Region : Global

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    Regular Price: USD 1,500

    Special Price USD 1,275

    Read More
  5. Analysis of the European HIV Drugs Market
    23
    Jan 2013

    Analysis of the European HIV Drugs Market

    Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

    Region : North America

    Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

    Regular Price: USD 4,950

    Special Price USD 4,208

    Read More
  6. Analysis of European HIV Diagnostics Market
    07
    Dec 2012

    Analysis of European HIV Diagnostics Market

    Increasing Adoption of HIV Nucleic Acid Testing (NAT) and Automation Spurs Market Growth.

    Region : Europe

    The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

    Regular Price: USD 4,950

    Special Price USD 3,713

    Read More
  7. Rapid Advances in HIV/AIDS Clinical Diagnostics (Technical Insights)
    30
    Jun 2009
    This research service provides the latest trends in HIV molecular diagnostics and discusses the prospects of future developments in this segment.

    Regular Price: USD 4,950

    Special Price USD 3,465

    Read More
  8. European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
    11
    Jun 2009
    This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these market...

    Regular Price: USD 4,950

    Special Price USD 3,465

    Read More
  9. European HIV/AIDS Therapeutics Markets
    18
    Apr 2009
    This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the ...

    Regular Price: USD 4,950

    Special Price USD 3,465

    Read More
  10. HIV Drug Development--Emerging Technologies (Technical Insights)
    27
    Jun 2006
    This research service discusses technology developments in the HIV drugs sector.

    Regular Price: USD 4,950

    Special Price USD 3,465

    Read More

Sort By

1-10 of 16

Page:
  1. 1
  2. 2